Protagonist Therapeutics Inc sell StockNews.com
Start price
31.05.25
/
50%
€41.80
Target price
31.05.26
-
Performance (%)
75.84%
Price
18.12.25
€73.50
Summary
This prediction is currently active. The price for Protagonist Therapeutics Inc has massively increased, which is bad news for the SELL prediction by StockNews_com. This prediction currently runs until 31.05.26. The prediction end date can be changed by StockNews_com at any time. StockNews_com has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Protagonist Therapeutics Inc | -0.676% | -0.676% |
| iShares Core DAX® | -0.793% | 4.201% |
| iShares Nasdaq 100 | -2.376% | 0.857% |
| iShares Nikkei 225® | -2.701% | -0.147% |
| iShares S&P 500 | -1.689% | 1.244% |
Comments by StockNews_com for this prediction
In the thread Protagonist Therapeutics Inc diskutieren
Protagonist Therapeutics, Inc. (NASDAQ: PTGX) was downgraded by analysts at Wall Street Zen from a "hold" rating to a "sell" rating.
Ratings data for PTGX provided by MarketBeat
Stopped prediction by StockNews_com for Protagonist Therapeutics Inc
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€73.50
18.10.23
18.10.23
-
18.10.24
18.10.24
-
19.10.24
19.10.24
Protagonist Therapeutics Inc
Start price
Target price
Perf. (%)
€73.50
30.09.23
30.09.23
-
30.09.24
30.09.24
-
01.10.24
01.10.24